Bristol Myers Squibb at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Bristol Myers Squibb brings 17 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on bioanalysis, with hybrid and reagent-free LC-MS assays for protein biomarkers, protein degraders and antibody-drug conjugates. Its sessions also cover where lipid nanoparticles and gene and cell therapies travel in the body, and drug release from biodegradable implants.

OrganizationAAPS 2026 PharmSci 360 Attendance
Large pharma
Global pharmaceutical company with medicines in oncology, immunology, cardiovascular disease and neuroscience.
Session
Mon Oct 26
9:00am–11:00am
Symposium: Biodistribution and Persistence as the New Exposure Science for Gene & Cell Therapies: From Vectors to Living Drugs
Preclinical, Clinical, and Translational Sciences
Talk
Mon Oct 26
10:00am–10:30am
Part of Symposium: Integrating AI, Biomarkers, and Modeling to Advance Translational Drug Development
Mining PK and Immunogenicity Data to Build Predictive AI/ML NAM-Models
207
Preclinical, Clinical, and Translational Sciences
Talk
Mon Oct 26
10:30am–11:00am
Part of Symposium: Biodistribution and Persistence as the New Exposure Science for Gene & Cell Therapies: From Vectors to Living Drugs
Beyond Hepatic Tropism: Mechanistic Drivers and Design Strategies for Tissue‑Targeted LNP Biodistribution
206
Preclinical, Clinical, and Translational Sciences
Poster
Mon Oct 26
12:30pm–1:30pm
Full Length CTGF and Full Length + N-Terminus CTGF Assay Validation and Analysis of Healthy Donor and Various Disease Sample
Solution Center · Poster M1230-06-34
Preclinical, Clinical, and Translational Sciences
Session
Mon Oct 26
3:00pm–4:00pm
Rapid Fire: Pushing the Boundaries of Hybrid LC-MS Bioanalysis
Bioanalytics
Talk
Mon Oct 26
3:00pm–3:15pm
Part of Rapid Fire: Pushing the Boundaries of Hybrid LC-MS Bioanalysis
Reagent-Free Versus Hybrid LC-MS Assays for Quantitation of Protein Biomarkers
203-205
Bioanalytics
Poster
Mon Oct 26
3:30pm–4:30pm
Developing A Robust HPLC Impurity Method for A Pharmaceutical Intermediate with Pre-column Derivatization
Solution Center · Poster M1530-04-21
Manufacturing and Analytical Characterization - Chemical
Talk
Mon Oct 26
3:30pm–4:30pm
Hot Topic: Navigating CMC Strategy in the Current Landscape
208-209
Manufacturing and Analytical Characterization · with AbbVie, Merck & Co., Pfizer
Poster
Tue Oct 27
11:30am–12:30pm
Comparison of Olink Neurodegeneration Panel and NULISA CNS Disease Panel
Solution Center · Poster T1130-07-38
Preclinical, Clinical, and Translational Sciences
Poster
Tue Oct 27
12:30pm–1:30pm
Reagent-Free LC-MRM Assay Pipeline for Biomarkers Quantification: Opportunities and Future Directions in Translational Research
Solution Center · Poster T1230-07-41
Preclinical, Clinical, and Translational Sciences
Talk
Tue Oct 27
1:30pm–2:30pm
Keynote: The AI-Orchestrated Bioanalysis Lab as a Strategic Asset in Drug Development
203-205
Bioanalytics · with Beam Therapeutics
Talk
Tue Oct 27
3:00pm–3:15pm
Part of Rapid Fire: Turning Bioanalytical Challenges into Reliable Answers
Overcoming Bioanalytical Challenges in Protein Degrader Quantitation Using Automated DPX-SPE
211-213
Bioanalytics
Session
Tue Oct 27
3:00pm–4:00pm
Rapid Fire: Turning Bioanalytical Challenges into Reliable Answers
Bioanalytics
Poster
Wed Oct 28
9:30am–10:30am
Mechanistic Understanding of Drug Release from PLGA- and PLA-Based Biodegradable Implants
Solution Center · Poster W0930-09-51
Formulation and Delivery - Chemical
Talk
Wed Oct 28
10:00am–10:30am
Part of Symposium: Adaptive Dosage Modifications - MIDD Opportunities & Challenges
Longitudinal Exposure-Response Modeling of Bounded Outcome Scores with Dose Modifications
206
Preclinical, Clinical, and Translational Sciences
Talk
Wed Oct 28
3:00pm–3:15pm
Part of Rapid Fire: Beyond Conventional Samples: Approaches in Tissue Bioanalysis and Biosensing
Measurement of Antibody–Drug Conjugate in Formalin Fixed Paraffin Embedded Tumor
211-213
Bioanalytics
Talk
Wed Oct 28
3:15pm–3:30pm
Part of Rapid Fire: Advanced Modalities, Biologics & Next-Generation Characterization
Biodegradable Implants: Bridging In Vitro Insights with In Vivo Outcomes
225-227
Manufacturing and Analytical Characterization

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bristol Myers Squibb

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction